Insider Trading Activity GenMark Diagnostics, Inc. (NASDAQ:GNMK) – CFO Sold 1,752 shares of Stock

ME Staff
-
0

Insider Trading Activity For GenMark Diagnostics, Inc. (NASDAQ:GNMK)

Scott Mendel , CFO of GenMark Diagnostics, Inc. (NASDAQ:GNMK) reportedly Sold 1,752 shares of the company’s stock at an average price of 10.16 for a total transaction amount of $17,800.32 SEC Form

Insider Trading History For GenMark Diagnostics, Inc. (NASDAQ:GNMK)

  • On 7/1/2013 Jon Faiz Kayyem, SVP, sold 6,000 with an average share price of $10.40 per share and the total transaction amounting to $62,400.00.View SEC Filing
  • On 8/20/2013 Jon Faiz Kayyem, SVP, sold 1,310 with an average share price of $10.15 per share and the total transaction amounting to $13,296.50.View SEC Filing
  • On 9/3/2013 Jon Faiz Kayyem, SVP, sold 1,545 with an average share price of $11.60 per share and the total transaction amounting to $17,922.00.View SEC Filing
  • On 9/3/2013 Hany Massarany, CEO, sold 2,354 with an average share price of $11.60 per share and the total transaction amounting to $27,306.40.View SEC Filing
  • On 9/4/2013 Jeffrey Alan Hawkins, SVP, sold 1,890 with an average share price of $11.60 per share and the total transaction amounting to $21,924.00.View SEC Filing
  • On 10/1/2013 Jon Faiz Kayyem, SVP, sold 6,000 with an average share price of $12.14 per share and the total transaction amounting to $72,840.00.View SEC Filing
  • On 10/9/2013 Hany Massarany, CEO, sold 3,925 with an average share price of $12.05 per share and the total transaction amounting to $47,296.25.View SEC Filing

    • Analyst Ratings For GenMark Diagnostics, Inc. (NASDAQ:GNMK)
    These are 4 Buy Ratings .
    The current consensus rating for GenMark Diagnostics, Inc. (NASDAQ:GNMK) is Buy (Score: 3.00) with a consensus target price of $16.25 , a potential (62.66% upside)

    Analyst Ratings History For GenMark Diagnostics, Inc. (NASDAQ:GNMK)

    • On 2/26/2016 Raymond James Financial, Inc. Lower Price Target of rating Outperform with a price target of $9.00 to $7.25
    • On 7/29/2016 J P Morgan Chase & Co Boost Price Target of rating Overweight with a price target of $10.00 to $13.00
    • On 5/17/2017 BTIG Research Reiterated Rating Buy with a price target of $17.00
    • On 6/13/2017 Needham & Company LLC Boost Price Target of rating Buy to Buy with a price target of $16.00 to $17.00
    • On 8/2/2017 Cowen and Company Reiterated Rating Outperform with a price target of $17.00
    • On 8/7/2017 Canaccord Genuity Reiterated Rating Buy with a price target of $17.00 to $14.00

    Recent Trading Activity for GenMark Diagnostics, Inc. (NASDAQ:GNMK)
    Shares of GenMark Diagnostics, Inc. closed the previous trading session at 9.99 down -0.10 -0.99% with 205,246 shares trading hands.